TCL Archive Switch To NTP Holds Down Entry Of New Compounds; Obey Supports NCI On Need For More Positions March 16, 1979
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited May 28, 1976
TCL Archive In Brief: NBA, NCI Signs Agreement On Content OF PSAs; Broder Talks To NBA Wives; ASC Honors Frei May 22, 1992
TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
